Today Gilbert is working hard to further develop their Smart Precision Inhaler, a device that can produce a customizable monodisperse aerosol. As of mid 2024, Gilbert is performing feasibility studies with Pharma partners to support the development and formulation for inhaled medicine.
Gilbert is hiring a System Architect based at our office on the High Tech Campus Eindhoven.
At Gilbert we are developing a next-generation soft mist inhaler with a revolutionary new approach, based on our proprietary electrospray technology.
Are you interested to join our team to redefine treatment for lung patients ?
For a full description of the postion, please visit: https://gilbert.eu/vacancy/system-architect/
We are always happy to welcome talented new people. If you cannot find an open position that you’d like to apply for, submit an open application by sending an email to info@gilbert.eu, with the subject ‘Open application’.
Please include your resume and a motivation letter that explains how you would like to contribute.
Electrospray ionization (ESI) is a technique used in mass spectrometry to produce ions using an electrospray in which a high voltage is applied to a liquid to create an aerosol. It is especially useful in producing ions from macromolecules because it overcomes the propensity of these molecules to fragment when ionized.
Electrospray technology is a promising alternative to plasma-based technologies for electric propulsion systems, with electrospray thrusters currently propelling satellites in space.
Electrohydrodynamic atomization (EHDA), also called electrospray, has been studied for centuries starting in the late 1500s when William Gilbert (1544-1603) first observed how a drop of water deformed into a cone in the presence of an electric field.
Since the 1990s electrospray has been successfully employed in applications across a broad range of industries, from biomedical, to nano-materials to food packaging to the aerospace industry.
The Gerard & Anton Awards ceremony highlights 10 promising start-ups in the Brainport Eindhoven region each year. Gilbert has been selected a one of the 2023 winners.
Click here for the article and interview.
Dutch MedTech Company Gilbert Raises €7 Million Series A to Redefine Treatment for Lung Patients.
Eindhoven, The Netherlands, June 7 2023 – Gilbert, today announced the completion of its €7 million Seed – and Series A investment round. The investment rounds are led by Dutch deeptech investor DeeptechXL and joined by existing shareholders NanoCorp and Delft Enterprises.
Click here for the full press release.
Engineering the inhaler of the future
What is the most important success factor to bring a medical technology from lab bench to hospital?
At the High Tech Campus Eindhoven Technology event, Maurits Huigen and Peter van den Bekerom discussed – on stage – how Gilbert and Philips Engineering Solutions partnered to develop the inhaler of the future.
Gilbert names Scott Fleming Chief Commercial Officer. Click here for the full press release.
